Diabetes Mellitus Type 2 Perspective

 
 
  • New Diabetes Guidelines Fail to Guide   An effort to encourage individualized treatment choices may muddy the therapy waters, says Dr Peters.
  • Spotlight on Retinal Diseases New anti-VEGF therapies for DME and AMD, as well as retinal detachment outcomes, were among the highlights presented at Retina Subspecialty Day during AAO 2017.
  • Type 2 Diabetes in Kids: Don't Miss It   Dr Tyree Winters stresses the importance of identifying at-risk kids and screening often, as much as annually, to be sure that early-stage type 2 diabetes is not missed.
  • What Cardiologists Need to Know About New Diabetes Drugs   Drs O'Donoghue and McGuire discuss the data on the various SGLT2 inhibitors and GLP1 receptor agonists and when to consider prescribing them to your patients with diabetes.
  • Diabetes Medications: Deprescribe Them in the Elderly? A new set of guidelines and an algorithm help clinicians decide when to pull back on antihyperglycemic drugs, including insulin.
  • Are Older Diabetes Drugs Safe and Effective?   You might have to prescribe older diabetes drugs to some patients so that they will be able to maintain treatment.
  • Ongoing Trials Put Focus Back on Fatty Liver Disease Researchers at this year's Liver Meeting offered promising insights into nonalcoholic steatohepatitis and fatty liver disease. Dr William Balistreri surveys their results.
  • ADA 2018 Abridged Standards: Update for Primary Care   What are the key changes in the 2018 ADA Abridged Standards for Diabetes Care that primary care clinicians should know?
  • National Diabetes Prevention Program: What You Need to Know   A new program cuts the risk of prediabetes progressing to type 2 diabetes by nearly 60%.
  • AHA Gastric Bypass for the Less Obese? Dr Walton-Shirley is reluctant to send obese patients for gastric bypass surgery, but concedes that the GATEWAY study findings are impressive.
  • When Is Evidence Enough to Justify Widespread Screening?   Just because we can screen for important diseases like diabetes or hepatitis C—should we?
  • Gestational Diabetes and Long-term Risk for CVD   Dr JoAnn Manson comments on a recent study revealing that gestational diabetes is like a window into a woman's future risk for cardiovascular disease and type 2 diabetes.
  • Coffee May Increase Life Expectancy in Liver Disease Steep benefits! The latest data link coffee consumption to decreased morbidity and mortality in liver disease.
  • Ultra-fast Insulins Curb Mealtime Spikes   Faster-acting insulins are especially beneficial for patients on continuous glucose monitors who are keeping track of glucose peaks and valleys.
  • Dapagliflozin: 'Helpful Strategy' for T1D?   Research presented at EASD 2017 shows that dapagliflozin may reduce insulin requirements with a low risk of adverse effects in patients with type 1 diabetes.
  • Insulin Access: A Casualty of Modern Medicine? Patients used to be able to obtain their insulin easily and cheaply. But the system of modern medicine is getting in the way, and many patients are stuck (pun intended).
  • In T2D, How Low Should BP Go? Should most patients with diabetes be on intensive blood pressure interventions?
  • An 85-Year-Old Woman With a Red, Painful Rash An 85-year-old woman with type 2 diabetes mellitus is admitted to the hospital because of a progressive, red, painful rash on her right leg. What's the next step in her treatment?
  • Diabetes Mellitus Overview Video   This video provides an overview of diabetes mellitus, including type 1, type 2, gestational diabetes, and drug-induced diabetes.
  • The Data Show What I Expected… In the absence of definitive clinical guidance, confirmation bias may guide decision making.